During the last 10–15 years, therapy with theophylline for the treatment of obstructive lung disease has been rationalized because of increased investigation into drug pharmacokinetics and metabolism and the introduction of new techniques for measuring drug concentration in plasma. Orally administered sustained-release preparations of theophylline have recently been introduced as therapy following the development of new technology. Such preparations allow more effective use of theophylline through increased patient compliance and the maintenance of more stable plasma theophylline concentrations.
Webb-JohnsonDCAndrewsJLJr: Bronchodilator therapy. N Engl J Med1977; 297: 758–764.
2.
FishmanAP: State of the art-chronic cor pulmonale. Am Rev Respir Dis1976; 114: 775–794.
3.
AlexanderMRDullWLKasikJE: Treatment of chronic obstructive pulmonary disease with orally biadministered theophylline. J Am Med Assoc1980; 244: 2286–2290.
4.
CampoSChiappiniMGDi GiulioC: La prescrizione dei teofillinici. Il Policlin Sez Prat1982; 89: 298–311.
5.
CampoSChiappiniMGCollocaA: Sustained release theophylline administration versus continuous theophylline infusion in old patients with acute respiratory failure. Eur J Respir Dis1980; 64 (suppl 126): 538.
6.
OgilvieRJ: Clinical pharmacokinetics of theophylline. Clin Pharmacokinet1978; 3: 267–293.
7.
SalterH: On some points in the treatment and clinical history of asthma. Edinb Med J1858–1859; 1109–1115.
8.
HerrmanGAynesworthMBMartinJ: Successful treatment of persistent dyspnea status asthmaticus. J Lab Clin Med1937; 23: 135–148.
9.
JenneJWWyzeERossFS: Pharmacokinetics of theophylline, application to and adjustment of the clinical dose of aminophylline. Clin Pharmacol Ther1972; 13: 349–360.
10.
HendelesLWeibergerMBighleyL: Disposition of theophylline after a single intravenous infusion of aminophylline. Annu Rev Respir Dis1978; 118: 97–103.
11.
SoldinSJAinJG: A rapid micromethod for measuring theophylline in serum by reversephase high performance liquid chromatography. Clin Biochem1977; 10: 74–77.
12.
IshizakiTWatanabeMMorisaitaM: The effect of assay method on plasma levels and pharmacokinetics of theophylline: HPLC and EIA. Br J Clin Pharmacol1979; 7: 333–341.
GoodsellEBSteinHHWenzkeKJ: 8-Substituted theophyllines. In vitro inhibition of 3‘, 5’-cyclic adenosine monophosphate phosphodiesterase and pharmacological spectrum in mice. J Med Chem1971; 14: 1202–1205.
15.
BaxterJH: Histamine release from rat mastcells by dextran: effects of adrenergic agents, theophylline, and other drugs. Proc Soc Exp Biol Med1972; 141: 576–581.
16.
MarquardtDLParkerCWSullivansTJ: Potentiation of mastcell mediator release by adenosine. J Immunol1978; 120: 871–878.
17.
JacobsMHSeniorRMKesslerG: Clinical experience with theophylline: relationship between dosage, serum concentration and toxicity. J Am Med Assoc1976; 235: 1983–1986.
18.
YannellPRChuNS: Focal seizures and aminophylline: Neurology (Minneap)1975; 25: 819–822.
19.
MitenkoPAOgilvieRJ: Rational intravenous dose of theophylline. N Engl J Med1973; 289: 600–603.
CharpinJ: Les taux plasmatiques de theophylline condamnent ils les formes enterales?Nouv Presse Med1978; 7: 2656.
22.
RuffF: Interet des dosages de la theophyllinemie. Nouv Presse Med1978; 7: 1750–1751.
23.
AndersenO: Absorption kinetics and steady-state plasma concentrations of theophylline following therapeutic doses of two sustained-release preparations. J Pharm Sci1983; 72: 158–165.
24.
WoodcockAA: Theophylline prescribing, serum concentration, and toxicity. Lancet1983; ii: 610–612.
25.
LeungPKaliskerABellTD: Variation in theophylline clearance rate with time in chronic childhood asthma. J Allergy Clin Immunol1977; 59: 440–444.
26.
WoodJHGarrettsonLK: The explanation of circadian rhythm for theophylline and other drugs. Lancet1983; ii: 570.
27.
WeibergerJHendelesLBighleyL: The relation of product formulation to absorption of oral theophylline. N Engl J Med1978; 299: 852–857.
28.
MeyerCMStranghnABLierbermanP: A multiple-dose study of sustained release theophylline and aminophylline. Chest1978; 78: 300–303.
29.
TinkelmanD: Theophylline: the concept of sustained action. J Asthma1981; 18: 35–37.
30.
MarchioniCFPenitentiSBernocchiD: Confronto tra i livelli plasmatici di Teonova liquido e di una preparazione galenica di Teofillina elisir. Biol Med1987; 9: 61–66.
31.
MonksTJSmithRLCaldwelJ: A metabolic and pharmacokinetic comparison of theophylline and aminophylline (theophylline athylendiamine). J Pharm Pharmacol1981; 33: 93–97.
32.
RallTW: In: The Xanthines: the Pharmacological Basis of Therapeutics (GilmanAGoodmanLS, eds). London: MacMillan, 1980; pp 592–598.
33.
HorrobinDFMankuMSFranksDJ: Theophylline and bronchospasm. N Engl J Med1977; 297: 1181.
34.
ClarkeSW: The Effect of Theophylline on Mucociliary Transport. Amsterdam: Excerpta Medica,. 1984; pp 22–25.
35.
MurcianoDAubierMLecorgnicY: Effects of theophylline and diaphragmatic strength and fatigue in patients with chronic obstructive pulmonary disease. N Engl J Med1984; 311: 349–353.
36.
WitingB: Prediction of response to theophylline in chronic bronchitis. Br J Clin Pharmacol1984; 17: 1–8.
37.
GodardP: Long term treatment with theophylline increases malonyldialdehyde plasma concentrations. Thorax1984; 39: 137–139.
38.
WolfeJDTashkinDPCalvaresB: Bronchodilator effects of terbutaline and aminophylline alone and in combination in asthmatic patients. N Engl J Med1978; 298: 363–367.
39.
BakranJJrUrhovacBPlavsicF: Aminophylline vs salbutamol in exercise-induced asthma. Int J Clin Pharmacol Ther Toxicol1980; 18: 442–446.
40.
McKayADBaldwinC: Action of intravenously administered aminophylline on normal airways. Am Rev Respir Dis1983; 127: 609–613.
41.
EstenneMYernaultJCDe TroyerA: Effects of parenteral aminophylline on lung mechanics in normal humans. Am Rev Respir Dis1980; 121: 967–971.
PolsonJB: Inhibition of human pulmonary phosphodiesterase activity by therapeutic levels of theophylline. Clin Exp Pharmacol Physiol1978; 5: 539–549.
44.
HorrobinDFMankuMSFranksD: Methylxanthine phosphodiesterase inhibitors behave as prostaglandin antagonists in a perfused rat mesenteric artery preparation. Prostaglandins1977; 13: 33–40.
45.
LombardiCTrabucchiM: I farmaci bronchodilatatori. In: Note di Farmacologia dell'Apparato Respiratorio (Clup, ed). Milan, 1983; pp 153–208.
46.
FengerM: Plasma concentrations of the cyclic nucleotides adenosine 3‘,5’-monophosphate in healthy adults treated with theophylline. Pharmacology1982; 24: 215–221.
47.
DongesCHeitmannMJungbluthH: Effectiveness of theophylline to increase cyclic AMP levels and force of contraction in electrically paced guinea pig auricles. Comparison with isoprenaline, calcium and ouabain. Naunyn Schmiedebergs Arch Pharmacol1977; 301: 87–89.
MatthayRA: Effects of aminophylline upon right and left ventricular performance in chronic obstructive pulmonary disease. Non-invasive assessment by radionuclide angiocardiography. Am J Med1978; 65: 903–910.
50.
UrthalerFJamesTN: Both direct and neurically mediated components of the chronotropic actions of aminophylline. Chest1976; 70: 24–32.
51.
PfeiferHJGreenblattDJ: Clinical toxicity of theophylline in relation to cigarette smoking. Chest1978; 73: 455–459.
52.
GeismarPMarquardsenJSylvertJ: Controlled trial of intravenous aminophylline in acute cerebral infarction. Acta Neurol Scand1976; 54: 173–180.
53.
ChuSoong Shan: Bronchodilators. Part II: methylxanthines. Drugs Today1984; 20: 509–527.
54.
TempleJ: Drugs Affecting the Respiratory System. Washington DC: American Chemical Society, 1980; pp 285–299.
55.
RuggeriSBernocchiDBerte‘F: Clinical experience with two twice daily slow release theophylline preparations. J Int Med Res1987; 15: 170–178.
56.
CorsicoRMerigiA: The activity and tolerability of a new once daily theophylline preparation (Teonova). A multicentre study. Clin Trials J1986; 23: 359–371.
57.
HambletonG: Comparison of chromoglycate and theophylline in controlling symptoms of chronic asthma. Lancet1977; i: 381–385.
58.
TrembathPWBoobisSWRichensJ: A theophylline–biochemical pharmacology and pharmacokinetics. J Int Med Res1979; 7 (suppl 1): 4–15.
59.
SvedmyrN: Recent advances in pharmacotherapy of asthma. Theophyllines. Prog Respir Dis1980; 14: 206–214.
60.
HoraiYIshizakiTSasakiT: Individualized aminophylline therapy in patients with obstructive airway disease: oral dosage prediction from intravenous test dose. Eur J Clin Pharmacol1982; 23: 111–121.
61.
WyattRWeibergerMHendelesL: Oral theophylline dosage for the management of chronic asthma. J Pediatr1978; 92: 125–130.
62.
IsakssonBLinholmB: Blood plasma level of different theophylline derivatives following parenteral, oral and rectal administration. Acta Med Scand1962; 171: 33–38.
63.
TruittEBMckusickVAKrantzJC: Theophylline blood levels after oral, rectal and intravenous administration and correlation with diuretic action. J Pharmacol Exp Ther1950; 100: 309–315.
64.
BerdelDHeimannG: Clinical pharmacology of theophylline in children. Br J Clin Pract1984; 38: 29–36.
65.
HendelesLWeibergerMWyattR: Guide to oral theophylline therapy for the treatment of chronic asthma. Am J Dis Child1978; 132: 876–880.
66.
WeibergerMDHendelesLPharmD: Clinical pharmacology of drugs used for asthma. Ped Clin North Am1981; 28: 47–75.
67.
JankmanJHGUptonRA: Pharmacokinetic drug interactions with theophylline. Clin Pharmacokinet1984; 9: 309–314.
68.
FagerströmPOMellstrandTSwedmyrR: Absorption of theophylline from conventional and sustained-release tablets. Int J Clin Pharmacol Ther Toxicol1981; 19: 131–138.
69.
GreenERGreenAWLaneR: Absorption characteristics of sustained-release theophylline capsules administered in apple sauce. J Pediatr1981; 98: 832–834.
70.
HeinmannGMurgesauJBergtU: Influence of food intake on bioavailability of theophylline in premature infants. Eur J Clin Pharmacol1982; 22: 171–173.
71.
WatanabeHNakanoS: Time-dependent absorption of theophylline in man. J Clin Pharmacol1984; 24: 509–514.
72.
WeinbergerMHendelesLWongL: Relationship of formulation and dosing interval to fluctuation of serum theophylline concentration in children with chronic asthma. J Pediatr1981; 99: 145–152.
73.
MangioneAImhoffTELeeRV: Pharmacokinetics of theophylline in liver disease. Chest1978; 73: 616–622.
74.
RogersRJKaliskerA: In consistent absorption from a sustained-release theophylline preparation during continuous therapy in asthmatic children. J Pediatr1985; 106: 496–501.
75.
UtamaJKreuknietJ: Pharmacokinetics and pharmacodynamics of a short and long acting theophylline medication. Ther Toxicol1983; 21: 287–291.
ResarRKWalsonPFritzB: Effect of arterial pH on intravenous theophylline loading in chronic obstructive pulmonary disease. Am Rev Respir Dis1977; 115: 155.
89.
LevyGKoysookoR: Pharmacokinetic analysis of the effect of theophylline on pulmonary functioning in asthmatic children. J Pediatr1975; 86: 789–793.
90.
HendelesLBighleyLRichardsonRH: Frequent toxicity from i.v. aminophylline infusions in critically ill patients. Drug lntell Clin Pharm1977; 2: 12–18.
91.
ArwoodLLDastaJFFriedmanC: Placental transfer of theophylline: two case reports. Pediatrics1979; 63: 844–846.
92.
YehTFPidesRS: Transplacental aminophylline toxicity in a neonate. Lancet1977; i: 910.
93.
StecGPGreenberyPRuoTS: Kinetics of theophylline transfer to breast milk. Clin Pharmacol Ther1980; 28: 404–408.
94.
YurchakAMJuskoWJ: Theophylline secretion into breast milk. Pediatrics1976; 57: 518–520.
95.
BonatiMLatiniRMarraG: Theophylline metabolism during the first month of life and development. Pediatr Res1981; 15: 304–308.
96.
BoryCBaltassatPPorthaultM: Biotransformation of theophylline to caffeine in premature newborns. Lancet1978; ii: 1204–1205.
ReitbergDPBernhardHSchentagJ: Alteration of theophylline clearance and half-life in normal volunteers. Am J Intern Med1981; 95: 582–585.
106.
RuffF: Drug interferences with theophylline: absence of interaction between theophylline and ranitidine. Nouv Presse Med1982; 11: 3512–3515.
107.
BraterDCKaajarenS: Pharmacodynamics of the diuretic effects of aminophylline and acetazolamide alone and combined with furosemide in normal subjects. J Pharmacol Exp Ther1983; 227: 92–97.
TamburriniLRCuniGMianG: Digitaleteofillina: antagonismo della Teofillina nella farmacocinetica della digossina in alcuni soggetti vecchi intossicati. Prog Med1984; 40: 295–303.
110.
AndersonJLAyresWHollCA: Potential pharmacokinetic interaction between theophylline and prednisone. Clin Pharmacol1984; 3: 187–191.
111.
ManfrediRLVesselES: Inhibition of theophylline metabolism by long-term allopurinol administration. Clin Pharmacol Ther1981; 29: 224–229.
112.
MarquisJF: Phenytoin-theophylline interaction. N Engl J Med1982; 307: 1189–1190.
113.
LandayRAGonzalezMATaylorJC: Effect of phenobarbital on theophylline disposition. J Allergy Clin Immunol1978; 62: 27–29.
114.
HendelesLWeibergerM: Avoidance of interactions and side-effects during chronic therapy with theophylline. Eur J Respir Dis1980; 61 (suppl): 103–119.
115.
BurkleWSGwitdalaCJ: Evaluation of toxic serum theophylline concentrations. Am J Hosp Pharm1981; 38: 1164–1166.
116.
GaudreaultPWasonS: Acute pediatric theophylline overdose: a summary of 28 cases. J Pediatr1983; 102: 474–476.
117.
OlsonKRBenowitzNLWooOF: Theophylline overdose acute single ingestion versus chronic repeated overmedication. Am J Emergency Med1985; 3: 386–394.
118.
DuttAKDe SoyzaND: The effect of aminophylline on cardiac rhythm in advanced chronic obstructive pulmonary disease. Eur J Respir Dis1983; 64: 264–270.
119.
HelliwellMBerryD: Theophylline poisoning in adults. Br Med J1979; 2: 1114–1119.
120.
HorawitzLNShearJFMooreEN: Effects of aminophylline on the threshold for initiating ventricular fibrillation during respiratory failure. Am J Cardiol1975; 35: 376–379.
121.
FredholmBB: Cardiovascular and renal actions of methylxanthines. Prog Clin Biol Res1984; 158: 303–330.
122.
OpieLHMullerCNathanD: Evidence for the role of cyclic AMP as the second messenger of arrhythmogenic effect of beta-stimulation. Adv Cyclic Nucleotide Res1980; 12: 63–69.
123.
BibersteinMPFieglerMGWardDM: Use of beta-blockade and hemoperfusion for acute theophylline poisoning. West J Med1984; 141: 485–490.
124.
CurrySCVanceMV: The effects of toxic concentrations of theophylline on oxygen consumption, ventricular work and acid base balance and plasma catecholamine levels in the dog. Ann Emergency Med1985; 14: 554–561.
125.
JosephXWhitehurstVE: Enhancement of cardiotoxic effects of beta-adrenergic bronchodilators by aminophylline in experimental animals. Fund Appl Toxicol1981; 1: 443–447.
126.
WeibergerM: Theophylline for treatment of asthma. J Pediatr1978; 92: 1–7.
127.
JensenMHJorgensenS: Are theophylline induced seizures in man caused by inhibition of cerebral 5‘-nucleotidase activity?Acta Pharmacol Toxicol1984; 55: 331–334.
128.
EdwissonLFredholmBB: Characterisation of adenosine receptors in isolated cerebral arteries of cat. Br J Pharmacol1983; 80: 631–637.
129.
OberdorsterGLarryR: Influence of adenosine and lowered cerebral blood flow on the cerebrovascular effects of theophylline. Eur J Pharmacol1975; 30: 197–204.
130.
CovelliHDKnodelAR: Predisposing factors to apparent theophylline induced seizures. Ann Allergy1985; 54: 411–415.
131.
KearnyTEManoguerraAS: Theophylline toxicity and the beta adrenergic system. Ann Intern Med1985; 102: 766–769.
132.
BrownMJBrownDC: Hypokalemia from beta 2 receptor stimulation by circulating epinephrine. N Engl J Med1983; 309: 1414–1419.
133.
AdminDNHenryJA: Propanolol administration in theophylline overdose. Lancet1985; i: 520–521.
134.
OliwEAnggardEFredholmBB: Effect of indomethacin on the renal actions of theophylline. Eur J Pharmacol1977; 43: 9–16.
135.
GaudreaultPGuayJ: Theophylline poisoning. Pharmacological considerations and clinical management. Med Toxicol1986; 1: 169–191.
136.
EhlersMZaskeDESawchukRJ: Massive theophylline overdose, rapid elimination by charcoal hemoperfusion. J Am Med Assoc1978; 240: 474–475.
